Nintedanib, a potent small molecule inhibitor with the CAS number 656247-17-5, has emerged as a significant compound in the pharmaceutical research landscape, particularly for its dual role in targeting cancer and fibrotic diseases. As a triple angiokinase inhibitor, it effectively blocks key signaling pathways driven by VEGFR, PDGFR, and FGFR, which are implicated in tumor angiogenesis, growth, and the progression of fibrotic conditions like idiopathic pulmonary fibrosis (IPF).

For researchers and product formulators, understanding the specific applications and properties of Nintedanib free base is crucial. Its ability to inhibit the proliferation of cancer cells and the migration of fibroblasts makes it a highly sought-after intermediate for preclinical drug development. As a leading manufacturer and supplier of fine chemicals, we are committed to providing Nintedanib free base of exceptional purity, ensuring its efficacy in rigorous scientific studies.

The therapeutic potential of Nintedanib is rooted in its comprehensive inhibition profile. By targeting VEGFR, it disrupts the formation of new blood vessels essential for tumor survival and growth. Simultaneously, inhibition of PDGFR and FGFR plays a critical role in mitigating fibrotic processes, such as the excessive deposition of extracellular matrix characteristic of diseases like IPF. This multifaceted action makes Nintedanib a compound of great interest for pharmaceutical companies looking to buy or develop next-generation therapies.

Our role as a reliable supplier from China ensures that researchers have consistent access to this vital compound. We understand that sourcing pharmaceutical intermediates requires a high degree of confidence in the manufacturer. Our stringent quality control measures and comprehensive documentation, including Certificates of Analysis, provide the assurance needed for critical research applications. When you purchase Nintedanib free base from us, you are investing in quality and reliability.

The detailed chemical structure and properties of Nintedanib free base, including its molecular formula (C31H33N5O4) and its typical presentation as a yellow solid powder, are essential pieces of information for formulators and researchers. Its solubility profile, often requiring solvents like DMSO, also informs its practical use in laboratory settings. As a dedicated manufacturer, we provide this technical information to facilitate its effective utilization.

In conclusion, Nintedanib (CAS 656247-17-5) represents a significant advancement in targeting pathways critical to cancer and fibrotic diseases. As a committed supplier and manufacturer, we are here to support your research needs by providing high-quality Nintedanib free base. We encourage you to request a quote for your procurement needs and experience the difference that a quality-focused supplier can make in your research and development efforts.